TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04833959

Pilot Study of 89-Zr Panitumumab in Pancreas Cancer

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Business Decision”

The sponsor’s own words in the registry.

Life of this trial

20212022202320242025Planned start2021-03-26 (planned)Registered2021-04-02Withdrawn (as of)2024-06-21

Vital statistics

Status
Withdrawn
Phase
Phase 1
Sponsor
Stanford University
Sponsor type
University, hospital or other
Conditions
Pancreas Cancer
Interventions
89Zr-panitumumab
Participants
0
Sites
1
Countries
United States

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.